Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

A Resized Recall Image cb1November 27 2017

A Class 2 drugs recall for batches of Lipitor 80mg and of generic atorvastatin 80mg under the Almus livery has been issued.

The MHRA’s alert says: “Pfizer is recalling the above batches as a precaution due to an out of specification result for microbiological testing during routine stability studies on a batch of the product which was not released to the market.”

The batches in the recall “were identified as being potentially affected by the same issue during the root cause investigation, although no out of specification microbiological results have been reported for these batches.”

The three batches involved – T43166 and T43170 (Lipitor) and T43157 (Almus) – with pack sizes each of 28 film-coated tablets, have been distributed from August 30 onwards, and all have expiry date of January 31 2020.

Medical information enquiries should be directed to Pfizer Medical Information on 01304 616161. Stock enquires should be directed to the local branch of Alliance Healthcare.

MHRA Class 2 medicines recall    

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...